(Q43879300)

27 November 2017

title

Germline single nucleotide polymorphisms associated with response of urothelial carcinoma to platinum-based therapy: the role of the host (English)

1 reference

single-nucleotide polymorphism

27 November 2017

main subject

1 reference

1

1 reference

27 November 2017

Robert James Hamilton

3

1 reference

27 November 2017

13

K Offit

1 reference

27 November 2017

J Vijai

2

1 reference

27 November 2017

I Ostrovnaya

4

1 reference

27 November 2017

G Iyer

5

1 reference

27 November 2017

I R Garcia-Grossman

6

1 reference

27 November 2017

P H Kim

7

1 reference

27 November 2017

J A Przybylo

8

1 reference

27 November 2017

S Alanee

9

1 reference

27 November 2017

J C Riches

10

1 reference

27 November 2017

A M Regazzi

11

1 reference

27 November 2017

M I Milowsky

12

1 reference

27 November 2017

D F Bajorin

14

1 reference

27 November 2017

publication date

29 July 2013

1 reference

27 November 2017

1 reference

27 November 2017

volume

24

1 reference

27 November 2017

issue

9

1 reference

27 November 2017

page(s)

2414-2421

1 reference

Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT225

International phase III trial assessing neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: long-term results of the BA06 30894 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT225

Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data advanced bladder cancer (ABC) meta-analysis collaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT225

Randomized phase II/III trial assessing gemcitabine/ carboplatin and methotrexate/carboplatin/vinblastine in patients with advanced urothelial cancer "unfit" for cisplatin-based chemotherapy: phase II--results of EORTC study 30986.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT225

Pretreatment prognostic factors for survival in patients with advanced urothelial tumors treated in a phase I/II trial with paclitaxel, cisplatin, and gemcitabine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT225

p53 overexpression as a prognostic factor for advanced stage bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT225

Accumulation of nuclear p53 and tumor progression in bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT225

Assessing interactions between mdm-2, p53, and bcl-2 as prognostic variables in muscle-invasive bladder cancer treated with neo-adjuvant chemotherapy followed by locoregional surgical treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT225

Gene expression of ERCC1 as a novel prognostic marker in advanced bladder cancer patients receiving cisplatin-based chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT225

BRCA1 mRNA expression and outcome to neoadjuvant cisplatin-based chemotherapy in bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT225

Population differences in platinum toxicity as a means to identify novel genetic susceptibility variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT225

Pazopanib efficacy in renal cell carcinoma: evidence for predictive genetic markers in angiogenesis-related and exposure-related genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT225

Association between CYP2D6 polymorphisms and outcomes among women with early stage breast cancer treated with tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT225

Uridine diphosphate glucuronosyltransferase (UGT) 1A1 and irinotecan: practical pharmacogenomics arrives in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT225

Cyclin D1 G870A polymorphism is associated with risk and clinicopathologic characteristics of bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT225

Cyclin D1/cyclin-dependent kinase 4 interacts with filamin A and affects the migration and invasion potential of breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT225

Cyclin D1b variant promotes cell invasiveness independent of binding to CDK4 in human bladder cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT225

D-type cyclins in superficial and muscle-invasive bladder urothelial carcinoma: correlation with clinicopathological data and prognostic significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT225

Insulin breast cancer connection: confirmatory data set the stage for better care

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT225

The cell-polarity protein Par6 links Par3 and atypical protein kinase C to Cdc42

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT225

Partitioning-defective protein 6 regulates insulin-dependent glycogen synthesis via atypical protein kinase C

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT225

A human homolog of the C. elegans polarity determinant Par-6 links Rac and Cdc42 to PKCzeta signaling and cell transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT225

Src and caveolin-1 reciprocally regulate metastasis via a common downstream signaling pathway in bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT225

Genome-wide association study of survival in non-small cell lung cancer patients receiving platinum-based chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT225

The Scientific Foundation for personal genomics: recommendations from a National Institutes of Health-Centers for Disease Control and Prevention multidisciplinary workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT225

Genetic mapping in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT225

From Darwin's finches to canaries in the coal mine--mining the genome for new biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT225

21 January 2018

Identifiers

DOI

10.1093/ANNONC/MDT225

1 reference

27 November 2017

1 reference